Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 15, Issue 6, 2015, Pages 885-888

  Massele, Amos ^a   Burger, Johanita ^b   Katende Kyenda, Norah L ^c   Kalemeera, Francis ^d   Kenaope, Thatoyaone ^e,f   Kibuule, Dan ^d   Mbachu, Ogochukwu ^g   Mubita, Mwangana ^d   Oluka, Margaret ^h   Olusanya, Adedunni ⁱ   Paramadhas, Bene D Anand ^e,j   Van Zyl, Paulina ^k   Godman, Brian ^l,m  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b NORTH WEST UNIVERSITY   (South Africa)

^c WALTER SISULU UNIVERSITY   (South Africa)

^d UNIVERSITY OF NAMIBIA   (Namibia)

^e Nyangabwe Hospital   (Botswana)

^f NELSON MANDELA METROPOLITAN UNIVERSITY   (South Africa)

^g Rex and Nhlangano Pharmacy   (Swaziland)

^h UNIVERSITY OF NAIROBI   (Kenya)

ⁱ BABCOCK UNIVERSITY   (Nigeria)

^j UNIVERSITY OF SOUTH AFRICA   (South Africa)

^k UNIVERSITY OF THE FREE STATE   (South Africa)

^l KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^m UNIVERSITY OF STRATHCLYDE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; CARBAMAZEPINE; COTRIMOXAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EFAVIRENZ; GENERIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIINFECTIVE AGENT;

AFRICA; ANXIETY; CONFERENCE PAPER; DEPRESSION; DRUG INDICATION; DRUG MISUSE; DRUG SAFETY; DRUG UTILIZATION; EPILEPSY; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRRITABLE COLON; KNOWLEDGE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRESCRIPTION; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; SYMPOSIUM; UPPER RESPIRATORY TRACT INFECTION; WORKSHOP; DRUG THERAPY; MEDICATION COMPLIANCE; METHODOLOGY; STANDARDS;

AFRICA; ANTI-INFECTIVE AGENTS; DRUG THERAPY; DRUG UTILIZATION; HUMANS; MEDICATION ADHERENCE; RESEARCH DESIGN;

EID: 84949112646     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2015.1088386     Document Type: Conference Paper

References (26)

1. Massele A, Godman B, Adorka M, et al. Initiative to progress research on medicine utilization in Africa: formation of the Medicines Utilization Research in Africa group. Expert Rev Pharmacoecon Outcomes Res 2015;15(4):607-10
2. Wettermark B. The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol 2013;69(Suppl 1):43-51
3. Truter I. A review of drug utilisation studies and methodologies. Jordan Jn Pharmaceutical Sci 2008;1(2):91-104
4. Wettermark B, Godman B, Jacobsson B, Haaijer-Ruskamp FM. Soft regulations in pharmaceutical policy making: An overview of current approaches and their consequences. Appl Health Econ Health Policy 2009;7(3):137-47
5. Godman B, Wettermark B, van Woerkom M, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Front pharmacol 2014;5:106
6. Moon J, Godman B, Petzold M, et al. Different initiatives across Europe to enhance losartan utilisation post generics: Impact and implications. Front pharmacol 2014;5(Article 219):1-10
7. Furst J, Cizman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther 2015;13(2):279-89
8. WHO Collaborating centre for drug statistics methodology. Guidelines for ATC classification and DDD assignment 2015. Available from: www. whocc. no/filearchive/ publications/2015-guidelines. pdf
9. Holloway K, Mathai E, Gray A. Surveillance of community antimicrobial use in resource-constrained settings-experience from five pilot projects. Trop Med Int Health 2011;16(2):152-61
10. Adorka M, Mitonga HK, Lubbe M, et al. Assessment of the appropriateness of antibiotic prescriptions in Lesotho public hospitals: A novel methodology based on principles of antibiotic prescribing. J Public Health Africa 2014;5:354
11. Cacace M, Ettelt S, Mays N, Nolte E. Assessing quality in cross-country comparisons of health systems and policies: Towards a set of generic quality criteria. Health Policy 2013;112(1-2):156-62
12. Pereko D, Lubbe S, Essack S. Antibiotic use in Namibia: Prescriber practices for common community infections. S Afr Fam Pract 2015;1(1):1-5
13. Eriksen J, Nsimba SE, Minzi OM, et al. Adoption of the new antimalarial drug policy in Tanzania-a cross-sectional study in the community. Trop Med Int Health 2005;10(10):1038-46
14. Tumwikirize WA, Ogwal-Okeng JW, Vernby A, et al. Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci 2011;11(1):72-8
15. Dube NM, Tint KS, Summers RS. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010. Clin Infect Dis 2014;58(11): 1607-14
16. Ngari MM, Waithira N, Chilengi R, et al. Experience of using an open source clinical trials data management software system in Kenya. BMC Res notes 2014;7:845
17. Farahani M, Vable A, Lebelonyane R, et al. Outcomes of the Botswana national HIV/ AIDS treatment programme from 2002 to 2010: A longitudinal analysis. Lancet Glob Health 2014;2(1):e44-50
18. Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, et al. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol 2013;69(Suppl 1):73-8
19. Fadare JO, Agboola SM, Opeke OA, Alabi RA. Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital. Ther Clin Risk Manag 2013;6:115-20
20. Agyakwa WE, Lubbe MS, Burger JR, et al. Fluoroquinolone prescribing patterns in the private healthcare sector of South Africa, 2005-2012. Lat Am J Phar 2015;34(9):1-8
21. Gaida R, Truter I, Grobler C. Efavirenz: A review of the epidemiology, severity and management of neuropsychaiatric side effects. S Afr J Psychiatr 2015;21(3)
22. Katende-kyenda N, Lubbe M, Apalata T Determining factors associated with adherence rates to highly active antiretroviral therapy among patients attending a public healthcare facility in Mthatha, Eastern Cape. Basic Clin Pharmacol Toxicol 2014;115: 65-66
23. Tromp A. Co-morbidity of and treatment for irritable bowel syndrome, depression and anxiety in residents of retirement villages. Masters dissertation, University of Free State, South Africa
24. African grid science gateway. Pharmacology science gateway initiative. Available from: http://sgw. africa-grid. org/pharmacologyscience-gateway
25. Available from: http://muria. nmmu. ac. za/ Botswana-Workshop-and-Symposium-27-29-July-2015
26. Available from: http://muria. nmmu. ac. za/ Membership